MBA MD - ELYM Old Interim Officer

Insider

MBA MD is Interim Officer of ELYM Old
Age 63
Phone877 354 3689
Webhttps://eliemtx.com

ELYM Old Management Efficiency

The company has return on total asset (ROA) of (0.2454) % which means that it has lost $0.2454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3835) %, meaning that it created substantial loss on money invested by shareholders. ELYM Old's management efficiency ratios could be used to measure how well ELYM Old manages its routine affairs as well as how well it operates its assets and liabilities.
ELYM Old currently holds 349 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. ELYM Old has a current ratio of 17.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ELYM Old's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Rex CFAAnebulo Pharmaceuticals
64
Caroline GodfreyPepGen
N/A
Annick DeschoolmeesterPharvaris BV
52
John CPAMediciNova
N/A
Gregory RussottiCentury Therapeutics
58
Patrick AmstutzMolecular Partners AG
50
MD MBARezolute
N/A
RA MScPharvaris BV
44
Peter MDAcrivon Therapeutics, Common
62
MD MPHMediciNova
56
, MBAMolecular Partners AG
51
Yuichi MDMediciNova
75
Guizhong LiuAdagene
54
Michael PitznerMolecular Partners AG
N/A
Eric DevroeAcrivon Therapeutics, Common
46
Kenneth CundyAnebulo Pharmaceuticals
66
LLM JDRezolute
63
Shane WilliamsCentury Therapeutics
N/A
Conor RichardsonShattuck Labs
N/A
Jochen KnollePharvaris BV
74
Sonia DPHILPepGen
38
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. ELYM Old (ELYM) is traded on NASDAQ Exchange in USA and employs 9 people.

Management Performance

ELYM Old Leadership Team

Elected by the shareholders, the ELYM Old's board of directors comprises two types of representatives: ELYM Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ELYM. The board's role is to monitor ELYM Old's management team and ensure that shareholders' interests are well served. ELYM Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ELYM Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
Erin Lavelle, COO VP
MD MBA, Chief Officer
James JD, Gen VP
Jo PalmerPhillips, Chief Officer
Andrew MD, Principal Chairman
Valerie Morisset, Chief Development
Emily Pimblett, Principal Officer
BAO BCh, President CEO
Susan MS, VP Affairs
Robert MBA, CEO Pres
MBA MD, Interim Officer
Nishi MD, Senior Development

ELYM Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ELYM Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in ELYM Stock

If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities